VIMTALABS Intraday Analysis...

VIMTALABS Share Price

Open 102.95 Change Price %
High 103.15 1 Day -1.45 -1.42
Low 100.20 1 Week 4.20 4.35
Close 100.65 1 Month -8.15 -7.49
Volume 53983 1 Year 4.80 5.01
52 Week High 128.50
52 Week Low 59.25
VIMTALABS Important Levels
Resistance 2 103.38
Resistance 1 102.26
Pivot 101.33
Support 1 99.04
Support 2 97.92
NSE INDIA Most Active Stocks
IFCI 27.25 16.45%
VISESHINFO 0.40 0.00%
SAIL 55.25 3.17%
SBIN 266.65 2.60%
ICICIBANK 268.45 2.17%
JINDALSTEL 74.20 1.50%
TANLA 59.75 19.98%
HCL-INSYS 61.30 1.07%
SUZLON 14.75 -1.01%
VEDL 245.45 1.03%
More..
NSE INDIA Top Gainers Stocks
VKSPL 0.15 50.00%
SFL 1032.00 41.37%
SFL 1032.00 41.37%
SFL 1032.00 41.37%
RASOYPR 0.20 33.33%
PARASPETRO 0.25 25.00%
VIMALOIL 43.20 20.00%
ATNINTER 0.30 20.00%
EUROTEXIND 33.60 20.00%
TANLA 59.75 19.98%
More..
NSE INDIA Top Losers Stocks
INDIANHUME 400.40 -51.39%
SPYL 1.75 -18.60%
SURANAIND 3.85 -15.38%
GLOBOFFS 94.85 -14.43%
SRGINFOTEC 0.30 -14.29%
KARMAENG 51.80 -9.44%
BANARBEADS 46.00 -8.46%
ZENITHBIR 0.65 -7.14%
AUSOMENT 33.05 -7.03%
ASIL 0.70 -6.67%
More..

Vimta Labs Limited (NSE: VIMTALABS)

VIMTALABS Technical Analysis 1.5
As on 9th Dec 2016 VIMTALABS Share Price closed @ 100.65 and we RECOMMEND Buy for LONG-TERM with Stoploss of 84.52 & Sell for SHORT-TERM with Stoploss of 102.27 we also expect STOCK to react on Following IMPORTANT LEVELS.
VIMTALABS Target for December
1st Target up-side 122.4
2nd Target up-side 137.72
3rd Target up-side 153.04
1st Target down-side 78.7
2nd Target down-side 63.38
3rd Target down-side 48.06
VIMTALABS Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 50.89 Sideways
MFI (14) MFI is Above 80 Over Bought
CCI (20) CCI is 59.31 Sideways
WILLIAM %R (14) William %R is -35.86 Sideways
ADX (14) ADX is 19.46 Range Bound
PSAR Stoploss For Short Sell 108.52
10 Day Avg Volume Traded -54.50 % Less then 10 Day Average Volume
VIMTALABS Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.vimta.com
VIMTALABS Address
VIMTALABS
Plot Nos.: 142/2 and 142
IDA Phase II
Hyderabad, 500051
India
Phone: 91 40 2726 4141
Fax: 91 40 2726 3657
VIMTALABS Latest News
Clarification sought from Vimta Labs Ltd   Hindu Business Line   - 18th Mar 15
Vimta Labs surges 20% on heavy volumes   Business Standard   - 13th Mar 15
Vimta Labs Ltd gets favorable verdict on service tax disputes   Equity Bulls   - 23rd Oct 14
CRISIL ratings for Indian debt instruments-Aug 12   Reuters   - 12th Aug 14
Buy Vimta Labs, Wockhardt, Allahabad Bank: Manav Chopra   Moneycontrol.com   - 07th Jul 14
Vimta Labs fails to execute Rs 30 cr projects   Business Standard   - 19th Sep 12
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading ...   Hindu Business Line   - 09th Apr 12
Vimta Labs standalone Dec '14 sales at Rs 25.15 crore   Moneycontrol.com   - 29th Mar 12
European firm seen circling Vimta Labs   Daily News & Analysis   - 04th Jun 11
Vimta Labs Board to consider Dividend for 2009-10   Equity Bulls   - 25th Apr 10
Interactive Technical Analysis Chart Vimta Labs Limited ( VIMTALABS NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Vimta Labs Limited
VIMTALABS Business Profile
Vimta Labs Limited provides contract research and testing services primarily in India. It offers analytical testing services for food and agriculture products, and drugs and pharmaceuticals, as well as tests water samples for various purposes and specifications. The company also provides environmental assessment services, including site selection and liability studies; environmental impact assessments; environment management plans; carrying capacity based regional studies; environmental audits; solid and hazardous waste management; risk assessments and disaster management plans; occupational health and safety, industrial hygiene; environmental baseline monitoring for air, meteorology, water, soil, noise, ecology, socio-economic, demography, etc.; industrial emission source monitoring; offshore sampling and analysis of marine water and sediments; marine ecological studies; marine impact assessment; rehabilitation and resettlement studies; forestry and ecological studies; geo-technical studies; geological and hydro-geological studies; land use/ land cover studies based on remote sensing; socio-economic studies; due diligence studies; epidemiological studies; wasteland management studies; and study on bio-indicators, as well as offers various other services under environment chemistry. In addition, it provides clinical research services, including Phase-I/ bioequivalence studies, as well as screening and recruitment services; and conducts studies on arious dosage forms, such as tablets, capsules, extended release preparations, gels, jellies, transdermal patches, injectibles, etc. Further, the company offers clinical reference lab services; pre-clinical services, including drug discovery services to pharmaceutical and biotech companies in the areas of pharmacology, DMPK/ADME, toxicology, and bioanalytical; and services in the area of cell and molecular biology. Vimta Labs Limited was founded in 1984 and is based in Hyderabad, India.